July 19–20, 2025, Esseniot, a leading Chinese smart-laboratory provider, joined more than 300 IVD manufacturers and distributors at the 2nd Annual IVD Channel Development Summit to demonstrate how drone logistics can accelerate the shift to integrated regional diagnostics during July 19–20, 2025.

Keynote: Last-Mile Air Transport for Medical Consortia

Zhang Lin, North China Director for Smart Systems & Services, presented a case study on using unmanned aerial vehicles (UAVs) to move blood and pathology samples between hospitals in a tiered-care network. Compared with ground couriers, UAVs cut transit time by 60 % and eliminate delays caused by traffic congestion.The talk, selected as a "Premium Showcase," outlined deployment steps and regulatory pathways now being piloted in three provinces.

Roundtable: Charting Channel Transformation

Chairman Yao Yong joined hospital executives and distributors to discuss how labs can modernize without capital outlay.Esseniot’s modular service model—ranging from SaaS-based LIS upgrades to fully outsourced drone logistics—was highlighted as a practical route for distributors moving from product resale to managed services.

Exhibition: End-to-End Smart-Lab Suite

Esseniot and its partner Motian Aviation debuted four integrated solutions:

Drone + Regional Lab Center

• Autonomous UAVs link primary-care clinics to a central lab, backed by ground-based rovers for weather or no-fly contingencies.
• Live demo displayed a 5 km, 8-minute sample flight tracked in real time on a 3D hospital map.

Total Lab Automation

• Robotic tube sorting, pneumatic transport and AI-driven TAT monitoring reduce average sample turnaround by 45 %.

Consumables AI-Ops

• RFID-enabled cabinets forecast reagent demand and auto-trigger purchase orders, cutting stock-outs to near zero.

One-Scene Smart Lab

• A single dashboard unifies HVAC, biosafety alarms and instrument analytics for any size lab.

The summit concluded with Esseniot inviting distributors to co-develop pilot sites in 2025–2026, offering joint funding, regulatory guidance and performance-based revenue sharing.